EMD Serono, Inc.
EMD Website

Press Releases

2010
 07/28/2010 EMD SERONO, INC.: FDA GRANTS PRIORITY REVIEW TO CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MS
Rockland, Massachusetts
   English
06/17/2010 EMD SERONO RESUMES STIMUVAX CLINICAL PROGRAM IN LUNG CANCER
Rockland, Massachusetts
  English
06/05/2010

CILENGITIDE STUDY PROVIDES LONG-TERM FOLLOW-UP DATA IN GLIOBLASTOMA PATIENTS 
Rockland, Massachusetts

  English
05/05/2010 EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE FIRST RESULTS OF THEIR COLLABORATION TO ADVANCE DRUG DEVELOPMENT IN MULTIPLE SCLEROSIS
Rockland, Massachusetts
  English
03/05/2010

EMD SERONO, INC. NAMED ONE OF THE BEST PLACES TO WORK IN INDUSTRY BY THE SCIENTIST MAGAZINE
Rockland, Massachusetts

English
1/21/2010 TWO-YEAR RESULTS FROM CLARITY STUDY WITH CLADRIBINE TABLETS IN MULTIPLE SCLEROSIS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE
Rockland, Massachusetts
English
 
2009
12/16/2009 EMD SERONO, INC. AND NATIONALLY RANKED US HOSPITAL ANNOUNCE COLLABORATION IN BASIC AND CLINICAL RESEARCH IN MULTIPLE SCLEROSIS
Rockland, MA
  English
11/30/2009
EMD SERONO, INC. RECEIVES REFUSE TO FILE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Rockland, MA
  English
10/19/2009
EMD SERONO, INC. HOLDS TOPPING OFF CEREMONY TO MARK MILESTONE IN EXPANSION OF THE COMPANY'S BILLERICA, MA RESEARCH FACILITY
Rockland, MA
  English
10/05/2009
EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE          
Rockland, MA
  English
09/30/2009
EMD SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL ORAL SHORT-COURSE MULTIPLE SCLEROSIS THERAPY IN THE UNITED STATES          
Rockland, MA
  English
08/10/2009 EMD SERONO, INC. AND THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER ANNOUNCE COLLABORATION FOR PRECLINICAL RESEARCH, CLINICAL TRIALS         
Rockland, MA/Houston, TX
  English
05/27/2009 MULTIPLE SCLEROSIS - WHAT ARE PEOPLE WITH MS AND THEIR HEALTH CARE PROVIDERS REALLY THINKING?          
Rockland, MA/New York, NY
  English
05/01/2009 EMD Serono, Inc. and Fast Forward, LLC Commit $3 Million in 2009 To Early Stage Drug Development For Multiple Sclerosis
Rockland, MA/New York, NY
  English
04/29/2009

TWO-YEAR PHASE III DATA PRESENTED AT AAN 61ST ANNUAL MEETING SHOW POSITIVE OUTCOME OF CLADRIBINE TABLETS IN PATIENTS WITH MULTIPLE SCLEROSIS
Rockland, Massachusetts

  English
03/30/2009 EMD SERONO: NEW PHASE III DATA FOR CLADRIBINE TABLETS TO BE PRESENTED AT THE AMERICAN ACademY OF NEUROLOGY 61ST ANNUAL MEETING IN APRIL 2009 
Rockland, Massachusetts
  English
03/30/2009

EMD SERONO ANNOUNCES EXPANSION WITH RESEARCH SITE IN CAMBRIdGE, MASSACHUSETTS
Rockland, Massachusetts

  English
03/18/2009 EMD SERONO and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis
Rockland, Massachusetts
  English
01/23/2009 EMD SERONO’S ORAL INVESTIGATIONAL TREATMENT CLADRIBINE TABLETS FOR MULTIPLE SCLEROSIS SIGNIFICANTLY REDUCED RELAPSE RATE IN TWO-YEAR PHASE III PIVOTAL TRIAL
Rockland, Massachusetts
  English
01/12/2009

EMD Serono and Emmaus Medical Announce Promotional Rights Agreement for Zorbtive® in the United States
Rockland, Massachusetts

  English
2008
11/07/2008 EMD SERONO LAUNCHES LANDMARK PATIENT REGISTRY FOR EGG FREEZING
Rockland, Massachusetts
  English
10/29/2008 EMD SERONO AND THERATECHNOLOGIES ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR TESAMORELIN IN THE UNITED STATES
Rockland, Massachusetts
  English
10/9/2008 EMD SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE
Rockland, Massachusetts
  English
7/10/2008 EMD SERONO, INC. TO ADOPT REVISED AND STRENGTHENED PHRMA CODE
Rockland, Massachusetts
English
4/16/2008 EMD SERONO ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN MASSACHUSETTS
Geneva, Switzerland
English
2007
12/13/2007 EMD ANNOUNCES SUPPORT OF THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH
Geneva, Switzerland
English
12/6/2007 EMD SERONO LAUNCHES EASYPOD®, NEW ELECTRONIC GROWTH HORMONE INJECTION DEVICEGeneva, Switzerland English
7/2/2007 EMD SERONO LAUNCHES MS LIFELINES ACCESS MADE SIMPLE, A PROGRAM DESIGNED TO SIMPLIFY ACCESS TO MS THERAPY
Rockland, Massachusetts
English
2007
6/4/2007 MERCK SERONO S.A. TO TERMINATE REGISTRATION AND DUTY TO FILE REPORTS UNDER THE U.S. SECURITIES EXCHANGE ACT
Geneva, Switzerland
English
6/4/2007 CLOSING OF THE EXISTING SHARE-REPURCHASE PROGRAM OF UP TO CHF 750 MILLION BY JUNE 1, 2007
Geneva, Switzerland
English
4/5/2007 MERCK SERONO S.A. TO VOLUNTARILY DELIST AND DEREGISTER ITS BEARER SHARES AND AMERICAN DEPOSITARY SHARES (EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS)
Geneva, Switzerland
English
3/21/2007 MERCK INITIATES SQUEEZE OUT PROCEDURE FOR SHARES OF MERCK SERONO S.A.
Geneva, Switzerland
English
3/21/2007 MERCK SERONO CONFIRMS PREVIOUSLY ANNOUNCED 2006 FIGURES
Geneva, Switzerland
English
2/28/2007 MERCK KGAA HOLDS NEARLY ALL VOTING RIGHTS IN MERCK SERONO S.A.
Geneva, Switzerland
English
1/9/2007 MERCK KGaA ANNOUNCES PUBLIC TENDER OFFER FOR MERCK SERONO SHARES
Geneva, Switzerland
English
1/8/2007 MERCK SERONO IS LAUNCHED
Geneva, Switzerland
English
1/5/2007 MERCK KGAA ACQUIRES MARJORITY SHAREHOLDING IN SERONO S.A.
Geneva, Switzerland
English
 
top
Disclaimer
This site contains medical information that is intended for residents of the United States only and is not meant to be a substitute for the advice provided by a medical professional. Always consult a healthcare provider if you have health concerns. For residents outside of the US, please go to www.merckserono.com for information.